Wenbing Yao

1.6k total citations
50 papers, 1.3k citations indexed

About

Wenbing Yao is a scholar working on Molecular Biology, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Wenbing Yao has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 9 papers in Pharmacology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Wenbing Yao's work include Diabetes Treatment and Management (8 papers), Polysaccharides and Plant Cell Walls (7 papers) and Pancreatic function and diabetes (5 papers). Wenbing Yao is often cited by papers focused on Diabetes Treatment and Management (8 papers), Polysaccharides and Plant Cell Walls (7 papers) and Pancreatic function and diabetes (5 papers). Wenbing Yao collaborates with scholars based in China, Macao and United States. Wenbing Yao's co-authors include Xiangdong Gao, Wei Liu, Xiangdong Gao, Wenhua Huang, Jing Xu, Dengke Yin, Suting Chen, Xiubing Pang, Wei Liu and Yan Sun and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Wenbing Yao

49 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenbing Yao China 19 570 372 205 179 136 50 1.3k
Wenna Zhang China 22 470 0.8× 546 1.5× 314 1.5× 266 1.5× 99 0.7× 47 1.5k
Jun Han China 25 611 1.1× 345 0.9× 166 0.8× 242 1.4× 77 0.6× 96 1.5k
Márcia Inês Goettert Brazil 22 814 1.4× 331 0.9× 137 0.7× 343 1.9× 108 0.8× 93 1.7k
Yuxi Guo China 23 396 0.7× 409 1.1× 256 1.2× 321 1.8× 75 0.6× 58 1.3k
Fangli Ma China 26 753 1.3× 405 1.1× 253 1.2× 263 1.5× 169 1.2× 66 1.6k
Najma Rahu China 7 584 1.0× 319 0.9× 155 0.8× 238 1.3× 191 1.4× 9 1.9k
Xianjing Hu China 20 548 1.0× 395 1.1× 261 1.3× 160 0.9× 72 0.5× 47 1.3k
Devina Lobine Mauritius 17 355 0.6× 290 0.8× 162 0.8× 175 1.0× 102 0.8× 43 1.2k
Ran Yin United States 24 724 1.3× 329 0.9× 104 0.5× 267 1.5× 71 0.5× 48 1.5k
Sivapragasam Gothai Malaysia 13 458 0.8× 386 1.0× 150 0.7× 186 1.0× 83 0.6× 24 1.5k

Countries citing papers authored by Wenbing Yao

Since Specialization
Citations

This map shows the geographic impact of Wenbing Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbing Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbing Yao more than expected).

Fields of papers citing papers by Wenbing Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenbing Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbing Yao. The network helps show where Wenbing Yao may publish in the future.

Co-authorship network of co-authors of Wenbing Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Wenbing Yao. A scholar is included among the top collaborators of Wenbing Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenbing Yao. Wenbing Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Meng, M. Fan, Yi Zhao, et al.. (2025). Low molecular weight Astragalus membranaceus polysaccharides alleviates dextran sulfate sodium-induced colitis in mice. Carbohydrate Polymers. 367. 124050–124050. 2 indexed citations
2.
Wang, Xin, et al.. (2024). Research on Core Competency Elements of Clinical Investigators. Therapeutic Innovation & Regulatory Science. 59(1). 45–53.
3.
Ji, Yue, Chen Xuan, Yuxi Zhang, et al.. (2024). Enhanced bioactivity and stability of a long-acting FGF21: A novel variant for the treatment of NASH. Biochimie. 225. 26–39. 1 indexed citations
6.
Yang, Yifan, Hong Luo, Yue Ji, et al.. (2023). A Versatile Platform for the Tumor‐Targeted Intracellular Delivery of Peptides, Proteins, and siRNA. Advanced Functional Materials. 33(30). 8 indexed citations
7.
Lu, Weisheng, Yongkang Wang, Peng Qian, et al.. (2021). An oral GLP-1 and GIP dual receptor agonist improves metabolic disorders in high fat-fed mice. European Journal of Pharmacology. 914. 174635–174635. 13 indexed citations
8.
Wei, Qingqing, et al.. (2019). Establishment of an HPLC-based method to identify key proteases of proteins in vitro. Analytical Biochemistry. 573. 1–7. 2 indexed citations
9.
Chen, Song, Suting Chen, Yan Sun, et al.. (2019). Fibroblast growth factor 21 ameliorates neurodegeneration in rat and cellular models of Alzheimer’s disease. Redox Biology. 22. 101133–101133. 92 indexed citations
10.
Huang, Yuankai, Dongning Yao, Weiwei Zhang, Yitao Wang, & Wenbing Yao. (2019). Do clerkship schemes effectively improve pharmacy students’ understanding of and attitudes regarding pharmaceutical care?——a pre-post study in China Pharmaceutical University. BMC Medical Education. 19(1). 425–425. 6 indexed citations
12.
Tang, Qian, Ying Wang, Xu Zheng, et al.. (2018). Evidence of metabolic memory-induced neurodegeneration and the therapeutic effects of glucagon-like peptide-1 receptor agonists via Forkhead box class O. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(2). 371–377. 15 indexed citations
13.
Chen, Xiaofei, et al.. (2017). Metabolic engineering of Bacillus subtilis for biosynthesis of heparosan using heparosan synthase from Pasteurella multocida, PmHS1. Bioprocess and Biosystems Engineering. 40(5). 675–681. 22 indexed citations
14.
Liu, Wei, Hong Wang, Juping Yu, et al.. (2016). Structure, chain conformation, and immunomodulatory activity of the polysaccharide purified from Bacillus Calmette Guerin formulation. Carbohydrate Polymers. 150. 149–158. 109 indexed citations
15.
Zhang, Zhenzhen, Wei Liu, Ying Zheng, et al.. (2013). SGP-2, an acidic polysaccharide from Sarcandra glabra, inhibits proliferation and migration of human osteosarcoma cells. Food & Function. 5(1). 167–175. 23 indexed citations
16.
Gao, Mingming, et al.. (2012). A site-specific PEGylated analog of exendin-4 with improved pharmacokinetics and pharmacodynamics in vivo. Journal of Pharmacy and Pharmacology. 64(11). 1646–1653. 10 indexed citations
17.
Yin, Dengke, et al.. (2009). Salidroside, the Main Active Compound ofRhodiolaPlants, Inhibits High Glucose-Induced Mesangial Cell Proliferation. Planta Medica. 75(11). 1191–1195. 28 indexed citations
18.
Chen, Mingjie, et al.. (2008). Site‐specific incorporation of unnatural amino acids into urate oxidase in Escherichia coli. Protein Science. 17(10). 1827–1833. 8 indexed citations
19.
Yin, Xiaojian, Wenbing Yao, & Yongmei Hu. (2008). Optimization of Gradient Separation for Chromatographic Fingerprint of Herbal Medicine: A Predictive Model Combined with Grid Search. Journal of Chromatographic Science. 46(8). 722–729. 2 indexed citations
20.
Pang, Xiaoyan, Xiao‐Ming Gao, Wei Liu, et al.. (2007). Potential of a Novel Polysaccharide Preparation (GLPP) from Anhui‐Grown Ganoderma lucidum in Tumor Treatment and Immunostimulation. Journal of Food Science. 72(6). S435–42. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026